MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer

被引：0
|
作者：
Sung Hwan Lee
Ho Kyoung Hwang
Woo Jung Lee
Chang Moo Kang
机构：
[1] CHA Bundang Medical Center,Department of Surgery
[2] CHA University School of Medicine,Laboratory of HBP Integrative Precision Oncology
[3] CHA Bio Complex,Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery
[4] CHA Health System,Pancreatobiliary Cancer Center
[5] Yonsei University College of Medicine,undefined
[6] Yonsei Cancer Center,undefined
[7] Severance Hospital,undefined
来源：
Cellular Oncology | 2021年 / 44卷
关键词：
Pancreatic cancer; MCT4; Gemcitabine; Chemotherapy; Pancreatectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1363 / 1371
页数：8
相关论文
共 50 条
  • [1] MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer
    Lee, Sung Hwan
    Hwang, Ho Kyoung
    Lee, Woo Jung
    Kang, Chang Moo
    CELLULAR ONCOLOGY, 2021, 44 (06) : 1363 - 1371
  • [2] MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis
    Kim, Hee Kyung
    Lee, InKyoung
    Bang, Heejin
    Kim, Hee Cheol
    Lee, Woo Yong
    Yun, Seong Hyeon
    Lee, Jeeyun
    Lee, Su Jin
    Park, Young Suk
    Kim, Kyoung-Mee
    Kang, Won Ki
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (04) : 838 - 848
  • [3] MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis
    Lee, Ji Yun
    Lee, InKyoung
    Chang, Won Jin
    Ahn, Su Min
    Lim, Sung Hee
    Kim, Hae Su
    Yoo, Kwai Han
    Jung, Ki Sun
    Song, Haa-Na
    Cho, Jin Hyun
    Kim, Sun Young
    Kim, Kyoung-Mee
    Lee, Soojin
    Kim, Seung Tae
    Park, Se Hoon
    Lee, Jeeyun
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    ONCOTARGET, 2016, 7 (28) : 43492 - 43503
  • [4] MCT4 is a novel target for prostate cancer
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (3) : 123 - 123
  • [5] MCT4 Expression in Pancreatic Cancer: Association with Prognosis, and Potential for Targeting Cancer Metabolism
    McFalls, J.
    Buboltz, N. D.
    Knudsen, E.
    Witkiewicz, A.
    MODERN PATHOLOGY, 2013, 26 : 428A - 428A
  • [6] MCT4 Expression in Pancreatic Cancer: Association with Prognosis, and Potential for Targeting Cancer Metabolism
    McFalls, J.
    Buboltz, N. D.
    Knudsen, E.
    Witkiewicz, A.
    LABORATORY INVESTIGATION, 2013, 93 : 428A - 428A
  • [7] The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer
    Choi, Stephen Yiu Chuen
    Xue, Hui
    Wu, Rebecca
    Fazli, Ladan
    Lin, Dong
    Collins, Colin C.
    Gleave, Martin E.
    Gout, Peter W.
    Wang, Yuzhuo
    CLINICAL CANCER RESEARCH, 2016, 22 (11) : 2721 - 2733
  • [8] MCT4 Defines a Metabolic Subtype of PDA with Poor Prognosis and Provides Potential Therapeutic Target
    Wachsmann, M.
    Tse, Y.
    Franco, J.
    Knudsen, E.
    Witkiewicz, A.
    LABORATORY INVESTIGATION, 2014, 94 : 456A - 457A
  • [9] MCT4 Defines a Metabolic Subtype of PDA with Poor Prognosis and Provides Potential Therapeutic Target
    Wachsmann, M.
    Tse, Y.
    Franco, J.
    Knudsen, E.
    Witkiewicz, A.
    MODERN PATHOLOGY, 2014, 27 : 456A - 457A
  • [10] Oncologic impact of monocarboxylate transporter 4 (MCT4) in pancreatic cancer
    Lee, Sung Hwan
    Kang, Chang Moo
    Hwang, Ho Kyoung
    Lee, Woo Jung
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345